Genetic predictions indicate a positive effect of Crohn’s Disease (CD) on the risk of Estrogen Receptor-Positive Breast Cancer (ER + BC), with (OR = 1.021; 95% CI:1.002–1.040; p = 0.002). This evidence concerns the gene ESR1 and Crohn disease.